Fluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae Clones, Spain

Emerging Infectious Diseases

Volumn 10, Issue 10, 2004, Pages 1751-1759

  De La Campa, Adela G ^a,e   Balsalobre, Luz ^a   Ardanuy, Carmen ^b   Fenoll, Asunción ^a   Pérez Trallero, Emilio ^c   Liñares, Josefina ^b   Pallarés, Román ^b   García, Ernesto ^d   Casal, Julio ^e   Fenoll, Asuncion ^e   Bouza, Emilio ^f   Baquero, Fernando ^g   Soriano, Francisco ^h   Prieto, José ^h   Garau, Javier ⁱ   Lacasa, Javier Martínez ⁱ   Latorre, Cristina ^j   González, Alberto ^c   De Lomas, Juan García ^k   Fleites, Ana ^l  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL DONOSTIA   (Spain)

^d CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^g HOSPITAL RAMÓN Y CAJAL   (Spain)

^h Grupo de Trabajo Ecografía SoMaMFyC   (Spain)

ⁱ HOSPITAL MÚTUA DE TERRASSA   (Spain)

^j HOSPITAL SANT JOAN DE DÉU   (Spain)

^k HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^l HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GATIFLOXACIN; GEMIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; DNA SEQUENCE; DRUG SENSITIVITY; GENETIC TRANSFORMATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; SOUTHERN BLOTTING; SPAIN; STREPTOCOCCUS PNEUMONIAE;

EID: 4844222942     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1010.040382     Document Type: Article

References (39)

1. Jacobs MR, Felmingham D, Appelbaum PC, Grüneberg RN, the Alexander Project Group. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother. 2003;52:229-46.
2. Muñoz R, Coffey TJ, Daniels M, Dowson CG, Laible G, Casal J, et al. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis. 1991;164:302-6.
3. Fenoll A, Jado I, Vicioso D, Pérez A, Casal J. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990-1996). J Clin Microbiol. 1998;36:3447-54.
4. Liñares J, de la Campa AG, Pallares R. Fluoroquinolone resistance in Streptococcus pneumoniae. N Engl J Med. 1999;341:1546-7.
5. Pérez-Trallero E, Fernádez-Mazarrasa C, Garcia-Rey C, Bouza E, Aguilar L, García de Lomas J, et al. Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob Agents Chemother. 2001;45:3334-40.
6. Chen DK, McGeer A, de Azavedo JC, Low DE. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N Engl J Med. 1999;341:233-9.
7. Doern GV, Heilmann KP, Huynh HK, Rhomberg PR, Coffman SL, Brueggemann AB. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob Agents Chemother. 2001;45:1721-9.
8. de Azevedo JCS, Trpeski L, Pong-Porter S, Matsumura S, Network TCBS, Low DE. In vitro activity of fluoroquinolones against antibiotic-resistant blood culture isolates of viridans group streptococci across Canada. Antimicrob Agents Chemother. 1999;43:2299-301.
9. Pérez-Trallero E, García-Arenzana JM, Jiménez JA, Peris A. Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin. Eur J Clin Microbiol Infect Dis. 1990;9:905-6.
10. Urban C, Rahman N, Zhao X, Mariano N, Segal-Maurer SA, Drlica K, et al. Fluoroquinolone-resistant Streptococcus pneumoniae associated with levofloxacin therapy. J Infect Dis. 2001;184:794-8.
11. Davidson R, Cavalcanti R, Brunton JL, Darrin J, Bast DJ, de Azevedo JCS, et al. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N Engl J Med. 2002;346:747-50.
12. Pérez-Trallero E, Marimon JM, Iglesias L, Larruskain J. Fluoroquinolone and macrolide treatment failure in pneumococcal pneumonia and selection of multidrug-resistant isolates. Emerg Infect Dis. 2003;9:1159-62.
13. González I, Georgiou M, Alcaide F, Balas D, Liñares J, de la Campa AG. Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci. Antimicrob Agents Chemother. 1998;42:2792-8.
14. de la Campa AG, Ferrándiz MJ, Tubau F, Pallares R, Manresa F, Liñares J. Genetic characterization of fiuoroquinolone-resistant Streptococcus pneumoniae strains isolated during ciprofloxacin therapy from a patient with bronchiectasis. Antimicrob Agents Chemother. 2003;47:1419-22.
15. Balas D, Fernández-Moreira E, de la Campa AG. Molecular characterization of the gene encoding the DNA gyrase A subunit of Streptococcus pneumoniae. J Bacteriol. 1998;180:2854-61.
16. Muñoz R, de la Campa AG. ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype. Antimicrob Agents Chemother. 1996;40:2252-7.
17. Janoir C, Zeller V, Kitzis M-D, Moreau NJ, Gutmann L. High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA. Antimicrob Agents Chemother. 1996;40:2760-4.
18. Pan X-S, Ambler J, Mehtar S, Fisher LM. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob Agents Chemother. 1996;40:2321-6.
19. Fernández-Moreira E, Balas D, Gonzalez I, de la Campa AG. Fluoroquinolones inhibit preferentially Streptococcus pneumoniae DNA topoisomerase IV than DNA gyrase native proteins. Microb Drug Resist. 2000;6:259-67.
20. Martín-Galiano AJ, de la Campa AG. High-efficiency generation of antibiotic-resistant strains of Streptococcus pneumoniae by PCR and transformation. Antimicrob Agents Chemother. 2003;47:1257-61.
21. Perichon B, Tankovic J, Courvalin P. Characterization of a mutation in the parE gene that confers fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother. 1997;41:166-7.
22. Ferrándiz MJ, Fenoll A, Liñares J, de la Campa AG. Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother. 2000;44:840-7.
23. Bast DJ, de Azevedo JCS, Tam TY, Kilburn L, Duncan C, Mandell LA, et al. Interspecies recombination contributes minimally to fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother. 2001;45:2631-4.
24. Yokota S, Sato K, Kuwahara O, Habadera S, Tsukamoto N, Ohuchi H, et al. Fluoroquinolone-resistant Streptococcus pneumoniae occurs frequently in elderly patients in Japan. Antimicrob Agents Chemother. 2002;46:3311-5.
25. Balsalobre L, Ferrándiz MJ, Liñares J, Tubau F, de la Campa AG. Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae. Antimicrob Agents Chemother. 2003;47:2072-81.
26. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Fourteenth informational supplement. NCCLS document M100-S14. Wayne (PA): The Committee; 2004.
27. Ferrándiz MJ, Oteo J, Aracil B, Gómez-Garcés JL, de la Campa AG. Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci. Antimicrob Agents Chemother. 1999;43:2520-3.
28. McGee L, McDougal L, Zhou J, Spratt BG, Tenover FC, George R, et al. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J Clin Microbiol. 2001;39:2565-71.
29. Tenover FC, Arbeit R, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulse-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233-9.
30. Enright MC, Fenoll A, Griffiths D, Spratt BG. The three major Spanish clones of penicillin-resistant Streptococcus pneumoniae are the most common clones recovered in recent cases of meningitis in Spain. J Clin Microbiol. 1999;37:3210-6.
31. Daily P, Gelling L, Rothrock G, Reingold A, Vugia D, Barrett NL, et al. Resistance of Streptococcus pneumoniae to fluoroquinolones - United States, 1995-1999. MMWR Morb Mortal Wkly Rep. 2001;50:800-4
32. Coffey T, Berron S, Daniels M, Garcia-Leoni M, Cercenado E, Bouza E, et al. Multiply antibiotic-resistant Streptococcus pneumoniae recovered from Spanish hospitals (1988-1994): novel major clones of serotypes 14, 19F and 15F. Microbiol. 1996;142:2747-57.
33. Pérez-Trallero E, Marimón JM, González A, Iglesias L. Spain14-5 international multiresistant Streptococcus pneumoniae clone resistant to fluoroquinolones and other families of antibiotics. J Antimicrob Chemother. 2003;51:715-9.
34. Ho PL, Yung RWH, Tsang DNC, Que TL, Ho M, Seto WH, et al. Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. J Antimicrob Chemother. 2001;48:659-65.
35. McGee L, Goldsmith CE, Klugman KP. Fluoroquinolone resistance among clinical isolates of Streptococcus pneumoniae belonging to international multiresistant clones. J Antimicrob Chemother. 2002;49:173-6.
36. Alou L, Ramirez M, García-Rey C, Prieto J, de Lencastre H. Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacin in Spain: clonal diversity and appearance of ciprofloxacin-resistant epidemic clones. Antimicrob Agents Chemother. 2001;45:2955-7.
37. Corso A, Severina EP, Petruk VF, Mauriz YR, Tomasz A. Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates causing respiratory disease in the United States. Microb Drug Resist. 1998;4:325-37.
38. Shi ZY, Enright MC, Wilkinson P, Griffiths D, Spratt BG. Identification of three major clones of multiply antibiotic-resistant Streptococcus pneumoniae in Taiwanese hospitals by multilocus sequence typing. J Clin Microbiol. 1998;36:3514-9.
39. Lim S, Bast D, McGeer A, de Azavedo J, Low DE. Antimicrobial susceptibility breakpoints and first-step parC mutation in Streptococcus pneumoniae: redefining fluoroquinolone resistance. Emerg Infect Dis. 2003;9:833-7.